A phase I clinical study of SJX-653 in postmenopausal women
Latest Information Update: 17 Jan 2019
At a glance
- Drugs SJX-653 (Primary)
- Indications Hot flashes
- Focus Adverse reactions
Most Recent Events
- 17 Jan 2019 New trial record
- 03 Jan 2019 According to a Sojournix pharma media release, the phase 1 trial is currently progressing.